These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 7084623)
1. Possible foodborne transmission in a case of pseudomembranous colitis due to Clostridium difficile: influence of gastrointestinal secretions on Clostridium difficile infection. Gurian L; Ward TT; Katon RM Gastroenterology; 1982 Aug; 83(2):465-9. PubMed ID: 7084623 [TBL] [Abstract][Full Text] [Related]
2. Role of Clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis. Peikin SR; Galdibini J; Bartlett JG Gastroenterology; 1980 Nov; 79(5 Pt 1):948-51. PubMed ID: 7419019 [TBL] [Abstract][Full Text] [Related]
3. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Viscidi R; Willey S; Bartlett JG Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125 [TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Gould LH; Limbago B Clin Infect Dis; 2010 Sep; 51(5):577-82. PubMed ID: 20642351 [TBL] [Abstract][Full Text] [Related]
5. Clostridia as agents of zoonotic disease. Songer JG Vet Microbiol; 2010 Jan; 140(3-4):399-404. PubMed ID: 19682805 [TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Adler SP; Chandrika T; Berman WF Am J Dis Child; 1981 Sep; 135(9):820-2. PubMed ID: 7282658 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections]. Barbut F; Petit JC Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603 [TBL] [Abstract][Full Text] [Related]
9. [Role of Clostridium difficile infection in the relapse of ulcerative colitis]. Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034 [TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile: epidemiology and clinical features. Marrie TJ; Furlong M; Faulkner RS; Sidorov J; Haldane EV; Kerr EA Can J Surg; 1982 Jul; 25(4):438-42. PubMed ID: 7093841 [TBL] [Abstract][Full Text] [Related]
11. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model. Freeman J; Baines SD; Saxton K; Wilcox MH J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547 [TBL] [Abstract][Full Text] [Related]
12. [Clostridium difficile infection. The nosocomial aspect]. Bucher A; Nordbø G Tidsskr Nor Laegeforen; 1995 Apr; 115(11):1361-4. PubMed ID: 7770832 [TBL] [Abstract][Full Text] [Related]
13. Basic and clinical aspects of Clostridium difficile colitis. Morishita T; Nakayama T; Kamiya T; Mori S; Isobe K; Furuta Y Rev Gastroenterol Peru; 2004; 24(3):263-9. PubMed ID: 15483687 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for the development of fulminant Clostridium difficile colitis. Greenstein AJ; Byrn JC; Zhang LP; Swedish KA; Jahn AE; Divino CM Surgery; 2008 May; 143(5):623-9. PubMed ID: 18436010 [TBL] [Abstract][Full Text] [Related]